AnticipatedClinical trial: Optional / allowed
Additional Ventures Single Ventricle Research Fund
Additional Ventures · Foundation
Source: Additional Ventures (curated) · View original posting ↗
Annual program; letters of intent are typically due in early October — next round not yet posted.
- AwardWhat a single award can be worth — the funder's published per-award amount or floor–ceiling range.
- Up to $600K
- DeadlineFinal application due date.
- Not yet posted
- Letter of intentDue date for the letter of intent (a short pre-application some funders require or request before the full proposal).
- —
- MechanismNIH activity code — the grant type (R01 research project, R21 exploratory, K series career development, F series fellowship, …).
- —
- DurationMaximum project period for a single award.
- 3 yr
- Expected awardsHow many awards the funder anticipates making under this opportunity.
- —
- Funding cycleHow often the program accepts applications (annual, multiple cycles per year, rolling, or one-time).
- Recurring (annual)
- Open dateWhen applications open (or opened).
- —
- Total fundingThe overall pool the funder expects to commit across ALL awards under this opportunity — not what one project receives.
- $600K total
- Clinical trialWhether proposed projects must, may, or must not include a clinical trial.
- Optional / allowed
Early careerEstablished investigatorHigher educationNonprofit
Research areas
Basic mechanisms & biologyTherapeutics & drug discoveryTraining & career development
Auto-classified from the title and description (keyword-based) — may be imperfect.
Description
Supports foundational studies to improve outcomes in single-ventricle heart disease through an Independent Investigator Track (up to $600,000 direct over three years) and a Career Development Track (up to $300,000), plus 10% indirect. Curated entry; verify current terms at the program page.
This funder has no public API, so the entry is manually curated — confirm current amounts, deadlines, and eligibility on the source page.